5 results match your criteria: "1 Hospital of Central Connecticut[Affiliation]"
The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients.
J Int Assoc Provid AIDS Care
September 2019
2 Columbia University Affiliated with Harlem Hospital Center, New York, NY, USA.
Current guidelines suggest that HIV-infected patients should receive chemoprophylaxis against Pneumocystis jirovecii pneumonia (PJP) if they have a cluster determinant 4 (CD4) count <200 cells/mm or oropharyngeal candidiasis. Persons with CD4 percentage (CD4%) below 14% should also be considered for prophylaxis. Discordance between CD4 count and CD4% occurs in 16% to 25% of HIV-infected patients.
View Article and Find Full Text PDFClinical Studies Targeting Stroke and Ischemic Insults.
Ther Hypothermia Temp Manag
March 2017
4 Department of Neurology, Friedrich-Alexander University, Erlangen, Germany .
Perspectives on Temperature Management.
Ther Hypothermia Temp Manag
December 2015
3 Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
MI to Cool?
Ther Hypothermia Temp Manag
September 2015
2 University of Connecticut, Farmington, Connecticut.
Targeted temperature management in nursing care.
Ther Hypothermia Temp Manag
September 2014
1 Hospital of Central Connecticut, New Britain, Connecticut.